Literature DB >> 18335665

Recent developments in targeting liver fibrosis.

John Iredale1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18335665

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  3 in total

1.  Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosis.

Authors:  Balakrishnan Chakrapani Narmada; Yuzhan Kang; Lakshmi Venkatraman; Qiwen Peng; Rashidah Binte Sakban; Bramasta Nugraha; Xuan Jiang; Ralph M Bunte; Peter T C So; Lisa Tucker-Kellogg; Hai-Quan Mao; Hanry Yu
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

Review 2.  Renin-angiotensin system in the pathogenesis of liver fibrosis.

Authors:  Regina Maria Pereira; Robson Augusto Souza dos Santos; Filipi Leles da Costa Dias; Mauro Martins Teixeira; Ana Cristina Simões e Silva
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

3.  Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats.

Authors:  Hongdong Xie; Yanyan Tao; Jing Lv; Ping Liu; Chenghai Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-29       Impact factor: 2.629
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.